BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7923076)

  • 1. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL).
    Decker HJ; Klauck SM; Lawrence JB; McNeil J; Smith D; Gemmill RM; Sandberg AA; Neumann HH; Simon B; Green J
    Cancer Genet Cytogenet; 1994 Oct; 77(1):1-13. PubMed ID: 7923076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome.
    Decker HJ; Gemmill RM; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1989 Jun; 39(2):289-93. PubMed ID: 2568884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ; Neuhaus C; Jauch A; Speicher M; Ried T; Bujard M; Brauch H; Störkel S; Stöckle M; Seliger B; Huber C
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific genetic change in tumors associated with von Hippel-Lindau disease.
    Tory K; Brauch H; Linehan M; Barba D; Oldfield E; Filling-Katz M; Seizinger B; Nakamura Y; White R; Marshall FF
    J Natl Cancer Inst; 1989 Jul; 81(14):1097-101. PubMed ID: 2738940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
    Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
    Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
    J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome.
    Goodman MD; Goodman BK; Lubin MB; Braunstein G; Rotter JI; Schreck RR
    Cancer; 1990 Mar; 65(5):1150-4. PubMed ID: 2302664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease.
    Jordan DK; Patil SR; Divelbiss JE; Vemuganti S; Headley C; Waziri MH; Gurll NJ
    Cancer Genet Cytogenet; 1989 Oct; 42(2):227-41. PubMed ID: 2790758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma.
    Lemeta S; Aalto Y; Niemelä M; Jääskeläinen J; Sainio M; Kere J; Knuutila S; Böhling T
    Cancer Genet Cytogenet; 2002 Mar; 133(2):174-8. PubMed ID: 11943349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
    Decker HJ; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A severely mentally and motor retarded girl with monosomy 3pter-->p25 and trisomy 8q24-->qter due to a familial reciprocal translocation t(3;8)(p25;q24).
    Balci S; Aypar E; Beksaç MS; Bartsch O
    Genet Couns; 2009; 20(2):125-32. PubMed ID: 19650409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.
    Seizinger BR; Smith DI; Filling-Katz MR; Neumann H; Green JS; Choyke PL; Anderson KM; Freiman RN; Klauck SM; Whaley J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2864-8. PubMed ID: 2011596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB.
    van der Hout AH; van der Vlies P; Wijmenga C; Li FP; Oosterhuis JW; Buys CH
    Genomics; 1991 Nov; 11(3):537-42. PubMed ID: 1685475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.